y 27632 has been researched along with Libman-Sacks Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Jia, X; Li, Y; Lu, Y; Wang, Q; Wang, Y; Wu, J; Xie, C; Ye, M; Zhang, J | 1 |
| Pernis, AB; Ricker, E; Rozo, C; Weng, CH; Yi, W | 1 |
| Hasni, SA; Kaplan, MJ; Kuai, R; Manna, Z; Mehta, NN; Pennathur, S; Playford, MP; Schwendeman, A; Seto, NL; Smith, CK; Vivekanandan-Giri, A; Yuan, W | 1 |
| Chai, J; Ge, M; He, W; Hu, X; Lu, Y; Sun, M; Wang, Y; Xie, C | 1 |
| Bykerk, VP; Chinenov, Y; Goodman, SM; Gupta, S; Kirou, KA; Leuenberger, L; Maharaj, RK; Pernis, AB; Rozo, C; Salmon, JE | 1 |
1 review(s) available for y 27632 and Libman-Sacks Disease
| Article | Year |
|---|---|
Rho Kinases in Autoimmune Diseases.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; B-Lymphocytes; Cell Movement; Cell Proliferation; Cell Survival; Cytoskeleton; Gene Expression; Giant Cell Arteritis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lupus Erythematosus, Systemic; Myeloid Cells; Osteoarthritis; Protein Kinase Inhibitors; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; Scleroderma, Systemic; T-Lymphocytes | 2016 |
4 other study(ies) available for y 27632 and Libman-Sacks Disease
| Article | Year |
|---|---|
[Protection of Rho-associated protein kinase inhibitor Y-27632 in MRL/lpr mice].
Topics: Amides; Animals; Carrier Proteins; Cytokines; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Mitogen-Activated Protein Kinases; NF-kappa B; Pyridines; rho-Associated Kinases | 2017 |
Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Activating Transcription Factor 3; Active Transport, Cell Nucleus; Amides; Animals; Cells, Cultured; Cytokines; Female; Humans; Lipoproteins, HDL; Lupus Erythematosus, Systemic; Macrophages; Mice; NF-kappa B; Oxidation-Reduction; Peptides; Protein Biosynthesis; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; RNA, Messenger; Scavenger Receptors, Class A; Scavenger Receptors, Class E; Sphingomyelins; Spleen; Toll-Like Receptors; Transcription, Genetic | 2017 |
Y-27632, a Rho-associated protein kinase inhibitor, inhibits systemic lupus erythematosus.
Topics: Amides; Animals; Cytokines; Female; Inflammation Mediators; Lupus Erythematosus, Systemic; Mice, Inbred MRL lpr; NF-kappa B; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Signal Transduction; Spleen; T-Lymphocytes, Regulatory | 2017 |
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
Topics: Adult; Aged; Amides; Arthritis, Rheumatoid; Case-Control Studies; Cells, Cultured; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-17; Interleukins; Lupus Erythematosus, Systemic; Male; Middle Aged; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Simvastatin; T-Lymphocytes; Th17 Cells | 2017 |